Waiting
登录处理中...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Gepooltes shRNA-Bibliotheksscreening zur…
JoVE Journal
Cancer Research
Author Produced

需要订阅 JoVE 才能查看此 内容. 登录或开始免费试用。

JoVE Journal Cancer Research
Gepooltes shRNA-Bibliotheksscreening zur Identifizierung von Faktoren, die einen Phänotyp der Arzneimittelresistenz modulieren
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Journal (Cancer Research)
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Journal (Cancer Research)
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
 
Click here for the English version

Gepooltes shRNA-Bibliotheksscreening zur Identifizierung von Faktoren, die einen Phänotyp der Arzneimittelresistenz modulieren

Article DOI: 10.3791/63383-v • 14:51 min • June 17th, 2022
June 17th, 2022 •
1,2, 1,2, 2,3, 2,3, 1,2,3, 1,2,3
1Department of Clinical Haematology, Christian Medical College, 2Department of Biotechnology, Thiruvalluvar University, 3Centre for Stem Cell Research, Christian Medical College

章节

总结概括
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Das RNAi-Screening (High-Throughput-RNA-Interferenz) unter Verwendung eines Pools lentiviraler shRNAs kann ein Werkzeug sein, um therapeutisch relevante synthetische tödliche Ziele in Malignomen nachzuweisen. Wir bieten einen gepoolten shRNA-Screening-Ansatz zur Untersuchung der epigenetischen Effektoren bei akuter myeloischer Leukämie (AML).

Tags

Krebsforschung Ausgabe 184 Hochdurchsatz-Screening RNAi-Screening shRNA epigenetischer Faktor Cytarabin AraC-Resistenz
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter